Business Context and Reporting Period
Company: GLOBALFOUNDRIES Inc. (GFS)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: A leading pure-play semiconductor foundry with manufacturing sites in the U.S. (Malta, NY; Burlington, VT), Germany (Dresden), and Singapore. The company focuses on essential chip solutions for automotive, IoT, communications, and smart mobile devices. It operates as a foreign private issuer incorporated in the Cayman Islands, with Mubadala Investment Company PJSC as its majority shareholder (81.5%).
Key Financial Metrics
| Metric (in millions, except per share) | 2024 | 2023 |
|---|---|---|
| Net Revenue | $6,750 | $7,392 |
| Gross Profit | $1,651 | $2,101 |
| Gross Margin | 24.5% | 28.4% |
| Operating Income (Loss) | $(214) | $1,129 |
| Net Income (Loss) | $(262) | $1,018 |
| Diluted EPS | $(0.48) | $1.83 |
| Operating Cash Flow | $1,722 | $2,125 |
| Capital Expenditures | $(625) | $(1,804) |
| Total Debt (Long-term + Current) | $1,806 | $2,372 |
| Cash & Cash Equivalents | $2,192 | $2,387 |
| Marketable Securities | $2,033 | $1,501 |
Material Changes vs. Prior Period
- Revenue Decline: Net revenue decreased 8.7% to $6.75 billion, driven by a 4% reduction in wafer shipment volume and a 3% decrease in average selling price (ASP). This was attributed to elevated customer inventory levels and weaker demand in Communications/Infrastructure and Home/IoT sectors.
- Significant Impairment Charge: The company recorded a non-cash impairment charge of $935 million related to legacy investments in production capacity at its Malta, New York facility. This charge was the primary driver of the shift from operating profit in 2023 to an operating loss in 2024.
- Margin Compression: Gross margin contracted by 390 basis points to 24.5% due to reduced factory utilization and unfavorable absorption of fixed costs.
- Debt Reduction: Total debt decreased by approximately $566 million year-over-year, aided by the prepayment of Term Loan A ($664 million) in January 2025 (subsequent event) and ongoing repayments during 2024.
- Share Repurchase: The company repurchased 3.9 million ordinary shares from its majority shareholder, Mubadala, for $200 million in May 2024.
Guidance, Outlook, and Risks
Outlook and Strategy: Management remains cautious regarding macroeconomic headwinds, including inflation and geopolitical tensions. The recovery is expected to be staggered across end markets, driven by inventory stabilization and the AI refresh cycle. The company plans to invest over $12 billion over the next 10+ years in its U.S. facilities (Fab 8 and Fab 9), contingent on government funding and customer demand. In November 2024, GF entered a Direct Funding Agreement with the U.S. Department of Commerce for up to $1.5 billion under the CHIPS and Science Act.
Key Risks and Contingencies:
- Internal Control Weaknesses: Management identified material weaknesses in Internal Control over Financial Reporting (ICFR) for 2024, resulting in an adverse opinion from auditors. Weaknesses included a lack of personnel with appropriate expertise and inadequate review of manual controls.
- Geopolitical and Trade Risks: Significant exposure to U.S.-China trade tensions, export controls, and tariffs. The company faces risks related to overcapacity in the industry, particularly from Chinese government-supported expansion.
- Supply Chain Concentration: Reliance on a single supplier (Soitec) for 61% of SOI wafers and a small number of customers for a significant portion of revenue.
- Regulatory Compliance: In 2024, the company incurred a civil penalty for inadvertent shipments to a firm on the BIS Entity List, which triggered events of default under debt agreements (subsequently waived by lenders).
Investor Verification Checklist
- ICFR Remediation: Verify the progress and timeline for remediation of the material weaknesses in internal controls identified in 2024.
- Impairment Details: Review the specific assumptions (discount rates, revenue growth) used in the $935 million impairment assessment for the Malta, NY facility.
- Government Funding: Monitor the status of the $1.5 billion CHIPS Act funding agreement and the $575 million New York State funding, including milestone requirements.
- Customer Concentration: Assess the impact of the top two customers (Customer A and B) representing a significant portion of wafer revenue.
- Debt Covenants: Confirm continued compliance with debt covenants, particularly following the 2024 export control breach and subsequent waivers.